Drug delivery systems for RNA therapeutics

Area of Science:

• Biotechnology
• Molecular Biology
• Pharmacology

Background:

• RNA-based gene therapies offer therapeutic potential but require efficient intracellular delivery.
• Non-viral drug delivery systems are crucial for overcoming the limitations associated with viral vectors.
• Ensuring RNA function within target cells without triggering adverse immune responses is paramount.

Purpose of the Study:

• To review current RNA therapeutic classes and their mechanisms of action.
• To discuss the design considerations for RNA delivery platforms.
• To outline the progression of drug delivery systems from preclinical research to clinical approval.

Main Methods:

• Literature review of RNA therapeutic classes.
• Analysis of molecular mechanisms of RNA action.
• Categorization of drug delivery systems (polymer-based, lipid-based, conjugate-based).
• Differentiation between passive and active targeting strategies.

Main Results:

• Overview of diverse RNA therapeutic classes and their specific delivery requirements.
• Detailed examination of polymer, lipid, and conjugate-based delivery systems.
• Distinction between passive and active cellular targeting approaches for enhanced specificity.
• Identification of key design considerations for optimizing RNA delivery platforms.

Conclusions:

• Non-viral delivery systems are essential for the advancement of RNA-based gene therapies.
• Strategic design of delivery platforms is critical for therapeutic efficacy and safety.
• Streamlining the discovery and development process for new drug delivery systems can accelerate clinical translation.